Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FCEL vs GSK✓SelectedUSD · GSKFCEL vs GSK performance historyLatest closeAs of-11.86%11/20
Stock and ETF performance explorer

FCEL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-82.0%
GSK return
+53.4%
Excess return
-135.4%
Maximum drawdown
-93.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-11.9%-0.1%-11.7%-11.9%
7D-30.9%-5.3%-25.6%-31.8%
30D-49.3%-3.7%-45.7%-49.6%
3M-63.6%-7.3%-56.3%-63.9%
6M-66.9%-4.2%-62.7%-66.9%
YTD-8.5%+0.9%-9.3%-11.0%
1Y+6.5%+7.3%-0.7%+2.1%
3Y-82.0%+52.7%-134.8%-87.5%
All-82.0%+53.4%-135.4%-87.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling